Multicentre Clinical Evaluation of a Molecular Diagnostic Assay to Identify Neisseria gonorrhoeae Infection and Detect Antimicrobial Resistance

Xiu, Leshan; Wang, Liqin; Li, Yamei; Hu, Lihua; Huang, Jia; Yong, Gang; Wang, Youwei; Cao, Wenling; Dong, Yuan; Gu, Wanyi; Peng, Junping

doi:10.1016/j.ijantimicag.2023.106785

Cited by 5 publications

(1 citation statement)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of FC428-like strains has continuously increased during 2015–2022 ( Figure 1 , panel A), possibly because of an actual increase in cases but also potentially because of advancements in sequencing technology and increased use of more straightforward AMR tests. In a surveillance initiative for FC428-like strains, researchers determined minimal inhibitory concentrations for ceftriaxone ( 8 ). In another study, researchers categorized isolates as ceftriaxone susceptible or ceftriaxone resistant according to the latest clinical breakpoints (version 14.0) from the European Committee on Antimicrobial Susceptibility Testing ( 9 ).…”

Section: The Studymentioning

confidence: 99%

Surge in Ceftriaxone-Resistant Neisseria gonorrhoeae FC428-Like Strains, Asia-Pacific Region, 2015−2022

Xiu,

Zhang,

Peng

2024

Emerg. Infect. Dis.

Self Cite

View full text Add to dashboard Cite

Ceftriaxone-resistant Neisseria gonorrhoeae FC428-like strains have disseminated across the Asia-Pacific region, with a continuous rise in prevalence during 2015–2022. To mitigate the effect of these strains, we advocate for enhanced molecular diagnostics, expanded surveillance networks, and a regionally coordinated effort to combat the global spread of FC428-like strains.

show abstract

Section: The Studymentioning

confidence: 99%